container_end_page 1206
container_issue 11
container_start_page 1200
container_title Archives de pédiatrie : organe officiel de la Société française de pédiatrie
container_volume 22
creator Lengellé, C
Bejan-Angoulvant, T
Beau-Salinas, F
Jonville-Béra, A P
description
doi_str_mv 10.1016/j.arcped.2015.08.001
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1727992392</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1727992392</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-d65137a9f598bc1d976412928aa2d44a34373824b4b2c022c493efd925d66ffa3</originalsourceid><addsrcrecordid>eNo1jlFLwzAURoMgbqv-AxEffWm99ya5SR5lOhUGvij4VtImlY12q8mK-O8VnPDBeTkcPiEuESoE5Ntt5VM7xlARoK7AVgB4IuZo2JXM6n0mFjlvAcCClWdiRiytZqXnYnGfpo98vYtf-Vycdr7P8eLIQrytHl6XT-X65fF5ebcuRyQ-lIE1SuNdp51tWgzOsEJyZL2noJSXShppSTWqoRaIWuVk7IIjHZi7zstC3Px1x7T_nGI-1MMmt7Hv_S7up1yjIeMcyd8V4uqoTs0QQz2mzeDTd_3_X_4AAt9EPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1727992392</pqid></control><display><type>article</type><title>Drugs news</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lengellé, C ; Bejan-Angoulvant, T ; Beau-Salinas, F ; Jonville-Béra, A P</creator><creatorcontrib>Lengellé, C ; Bejan-Angoulvant, T ; Beau-Salinas, F ; Jonville-Béra, A P</creatorcontrib><identifier>EISSN: 1769-664X</identifier><identifier>DOI: 10.1016/j.arcped.2015.08.001</identifier><identifier>PMID: 26385645</identifier><language>fre</language><publisher>France</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Angiotensin II Type 1 Receptor Blockers - therapeutic use ; Anti-Obesity Agents - adverse effects ; Anticonvulsants - adverse effects ; Aorta - drug effects ; Aortic Aneurysm - prevention &amp; control ; Atenolol - therapeutic use ; Cleft Palate - chemically induced ; Female ; Fructose - analogs &amp; derivatives ; Hemangioma - congenital ; Hemangioma - epidemiology ; Humans ; Losartan - therapeutic use ; Male ; Marfan Syndrome - drug therapy ; Pregnancy ; Prenatal Exposure Delayed Effects ; Skin Neoplasms - congenital ; Skin Neoplasms - epidemiology</subject><ispartof>Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2015-11, Vol.22 (11), p.1200-1206</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26385645$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lengellé, C</creatorcontrib><creatorcontrib>Bejan-Angoulvant, T</creatorcontrib><creatorcontrib>Beau-Salinas, F</creatorcontrib><creatorcontrib>Jonville-Béra, A P</creatorcontrib><title>Drugs news</title><title>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</title><addtitle>Arch Pediatr</addtitle><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Angiotensin II Type 1 Receptor Blockers - therapeutic use</subject><subject>Anti-Obesity Agents - adverse effects</subject><subject>Anticonvulsants - adverse effects</subject><subject>Aorta - drug effects</subject><subject>Aortic Aneurysm - prevention &amp; control</subject><subject>Atenolol - therapeutic use</subject><subject>Cleft Palate - chemically induced</subject><subject>Female</subject><subject>Fructose - analogs &amp; derivatives</subject><subject>Hemangioma - congenital</subject><subject>Hemangioma - epidemiology</subject><subject>Humans</subject><subject>Losartan - therapeutic use</subject><subject>Male</subject><subject>Marfan Syndrome - drug therapy</subject><subject>Pregnancy</subject><subject>Prenatal Exposure Delayed Effects</subject><subject>Skin Neoplasms - congenital</subject><subject>Skin Neoplasms - epidemiology</subject><issn>1769-664X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1jlFLwzAURoMgbqv-AxEffWm99ya5SR5lOhUGvij4VtImlY12q8mK-O8VnPDBeTkcPiEuESoE5Ntt5VM7xlARoK7AVgB4IuZo2JXM6n0mFjlvAcCClWdiRiytZqXnYnGfpo98vYtf-Vycdr7P8eLIQrytHl6XT-X65fF5ebcuRyQ-lIE1SuNdp51tWgzOsEJyZL2noJSXShppSTWqoRaIWuVk7IIjHZi7zstC3Px1x7T_nGI-1MMmt7Hv_S7up1yjIeMcyd8V4uqoTs0QQz2mzeDTd_3_X_4AAt9EPA</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Lengellé, C</creator><creator>Bejan-Angoulvant, T</creator><creator>Beau-Salinas, F</creator><creator>Jonville-Béra, A P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201511</creationdate><title>Drugs news</title><author>Lengellé, C ; Bejan-Angoulvant, T ; Beau-Salinas, F ; Jonville-Béra, A P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-d65137a9f598bc1d976412928aa2d44a34373824b4b2c022c493efd925d66ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2015</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Angiotensin II Type 1 Receptor Blockers - therapeutic use</topic><topic>Anti-Obesity Agents - adverse effects</topic><topic>Anticonvulsants - adverse effects</topic><topic>Aorta - drug effects</topic><topic>Aortic Aneurysm - prevention &amp; control</topic><topic>Atenolol - therapeutic use</topic><topic>Cleft Palate - chemically induced</topic><topic>Female</topic><topic>Fructose - analogs &amp; derivatives</topic><topic>Hemangioma - congenital</topic><topic>Hemangioma - epidemiology</topic><topic>Humans</topic><topic>Losartan - therapeutic use</topic><topic>Male</topic><topic>Marfan Syndrome - drug therapy</topic><topic>Pregnancy</topic><topic>Prenatal Exposure Delayed Effects</topic><topic>Skin Neoplasms - congenital</topic><topic>Skin Neoplasms - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lengellé, C</creatorcontrib><creatorcontrib>Bejan-Angoulvant, T</creatorcontrib><creatorcontrib>Beau-Salinas, F</creatorcontrib><creatorcontrib>Jonville-Béra, A P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lengellé, C</au><au>Bejan-Angoulvant, T</au><au>Beau-Salinas, F</au><au>Jonville-Béra, A P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drugs news</atitle><jtitle>Archives de pédiatrie : organe officiel de la Société française de pédiatrie</jtitle><addtitle>Arch Pediatr</addtitle><date>2015-11</date><risdate>2015</risdate><volume>22</volume><issue>11</issue><spage>1200</spage><epage>1206</epage><pages>1200-1206</pages><eissn>1769-664X</eissn><cop>France</cop><pmid>26385645</pmid><doi>10.1016/j.arcped.2015.08.001</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1769-664X
ispartof Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2015-11, Vol.22 (11), p.1200-1206
issn 1769-664X
language fre
recordid cdi_proquest_miscellaneous_1727992392
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adrenergic beta-Antagonists - therapeutic use
Angiotensin II Type 1 Receptor Blockers - therapeutic use
Anti-Obesity Agents - adverse effects
Anticonvulsants - adverse effects
Aorta - drug effects
Aortic Aneurysm - prevention & control
Atenolol - therapeutic use
Cleft Palate - chemically induced
Female
Fructose - analogs & derivatives
Hemangioma - congenital
Hemangioma - epidemiology
Humans
Losartan - therapeutic use
Male
Marfan Syndrome - drug therapy
Pregnancy
Prenatal Exposure Delayed Effects
Skin Neoplasms - congenital
Skin Neoplasms - epidemiology
title Drugs news
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A27%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drugs%20news&rft.jtitle=Archives%20de%20p%C3%A9diatrie%20:%20organe%20officiel%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20p%C3%A9diatrie&rft.au=Lengell%C3%A9,%20C&rft.date=2015-11&rft.volume=22&rft.issue=11&rft.spage=1200&rft.epage=1206&rft.pages=1200-1206&rft.eissn=1769-664X&rft_id=info:doi/10.1016/j.arcped.2015.08.001&rft_dat=%3Cproquest_pubme%3E1727992392%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1727992392&rft_id=info:pmid/26385645&rfr_iscdi=true